nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—IL1B—dermis—vitiligo	0.0728	0.189	CbGeAlD
Minocycline—MMP9—dermis—vitiligo	0.0606	0.157	CbGeAlD
Minocycline—CASP3—skin epidermis—vitiligo	0.0383	0.0995	CbGeAlD
Minocycline—CASP1—Inflammasomes—NLRP1—vitiligo	0.0346	0.0563	CbGpPWpGaD
Minocycline—CYCS—Activation of caspases through apoptosome-mediated cleavage—CASP7—vitiligo	0.0337	0.0549	CbGpPWpGaD
Minocycline—CASP1—Cellular roles of Anthrax toxin—NLRP1—vitiligo	0.0321	0.0522	CbGpPWpGaD
Minocycline—IL1B—skin epidermis—vitiligo	0.0306	0.0795	CbGeAlD
Minocycline—CASP3—Activation of caspases through apoptosome-mediated cleavage—CASP7—vitiligo	0.0272	0.0443	CbGpPWpGaD
Minocycline—CASP3—SMAC binds to IAPs—CASP7—vitiligo	0.0272	0.0443	CbGpPWpGaD
Minocycline—CYCS—Apoptotic factor-mediated response—CASP7—vitiligo	0.0258	0.0419	CbGpPWpGaD
Minocycline—MMP9—skin epidermis—vitiligo	0.0255	0.0662	CbGeAlD
Minocycline—CYCS—neck—vitiligo	0.0214	0.0556	CbGeAlD
Minocycline—CASP3—Apoptotic factor-mediated response—CASP7—vitiligo	0.0208	0.0338	CbGpPWpGaD
Minocycline—IL1B—Cellular roles of Anthrax toxin—NLRP1—vitiligo	0.0201	0.0326	CbGpPWpGaD
Minocycline—CASP1—NOD pathway—NLRP1—vitiligo	0.0195	0.0317	CbGpPWpGaD
Minocycline—CASP3—neck—vitiligo	0.0183	0.0476	CbGeAlD
Minocycline—CASP1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NLRP1—vitiligo	0.0166	0.0271	CbGpPWpGaD
Minocycline—CASP1—skin of body—vitiligo	0.0144	0.0374	CbGeAlD
Minocycline—CYCS—skin of body—vitiligo	0.0139	0.036	CbGeAlD
Minocycline—CASP3—Caspase-mediated cleavage of cytoskeletal proteins—CASP7—vitiligo	0.0135	0.022	CbGpPWpGaD
Minocycline—MMP9—neck—vitiligo	0.0122	0.0317	CbGeAlD
Minocycline—IL1B—NOD pathway—NLRP1—vitiligo	0.0122	0.0198	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—TYRP1—vitiligo	0.012	0.0196	CbGpPWpGaD
Minocycline—CASP3—skin of body—vitiligo	0.0119	0.0308	CbGeAlD
Minocycline—CYCS—Apoptosis Modulation by HSP70—CASP7—vitiligo	0.0116	0.0189	CbGpPWpGaD
Minocycline—CASP1—thyroid gland—vitiligo	0.0106	0.0275	CbGeAlD
Minocycline—CYCS—thyroid gland—vitiligo	0.0102	0.0265	CbGeAlD
Minocycline—IL1B—skin of body—vitiligo	0.00948	0.0246	CbGeAlD
Minocycline—CASP3—Apoptosis Modulation by HSP70—CASP7—vitiligo	0.00935	0.0152	CbGpPWpGaD
Minocycline—CASP3—thyroid gland—vitiligo	0.00873	0.0227	CbGeAlD
Minocycline—MMP9—skin of body—vitiligo	0.0079	0.0205	CbGeAlD
Minocycline—CYCS—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP7—vitiligo	0.00745	0.0121	CbGpPWpGaD
Minocycline—CASP1—NOD pathway—CASP7—vitiligo	0.00732	0.0119	CbGpPWpGaD
Minocycline—CYCS—Intrinsic Pathway for Apoptosis—GZMB—vitiligo	0.00727	0.0118	CbGpPWpGaD
Minocycline—IL1B—thyroid gland—vitiligo	0.00697	0.0181	CbGeAlD
Minocycline—VEGFA—thyroid gland—vitiligo	0.00686	0.0178	CbGeAlD
Minocycline—CYCS—Intrinsic Pathway for Apoptosis—CASP7—vitiligo	0.00666	0.0108	CbGpPWpGaD
Minocycline—CYCS—Parkinsons Disease Pathway—CASP7—vitiligo	0.00666	0.0108	CbGpPWpGaD
Minocycline—CYCS—Detoxification of Reactive Oxygen Species—CAT—vitiligo	0.00633	0.0103	CbGpPWpGaD
Minocycline—CYCS—FAS pathway and Stress induction of HSP regulation—CASP7—vitiligo	0.00615	0.01	CbGpPWpGaD
Minocycline—CASP3—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP7—vitiligo	0.00601	0.00978	CbGpPWpGaD
Minocycline—CASP3—Intrinsic Pathway for Apoptosis—GZMB—vitiligo	0.00587	0.00954	CbGpPWpGaD
Minocycline—CASP1—Amyotrophic lateral sclerosis (ALS)—CAT—vitiligo	0.00563	0.00915	CbGpPWpGaD
Minocycline—CASP3—Intrinsic Pathway for Apoptosis—CASP7—vitiligo	0.00537	0.00874	CbGpPWpGaD
Minocycline—CASP3—Apoptotic cleavage of cellular proteins—CASP7—vitiligo	0.00537	0.00874	CbGpPWpGaD
Minocycline—CASP3—Parkinsons Disease Pathway—CASP7—vitiligo	0.00537	0.00874	CbGpPWpGaD
Minocycline—CYCS—Caspase Cascade in Apoptosis—GZMB—vitiligo	0.00526	0.00855	CbGpPWpGaD
Minocycline—CASP3—FAS pathway and Stress induction of HSP regulation—CASP7—vitiligo	0.00496	0.00807	CbGpPWpGaD
Minocycline—CASP3—TWEAK Signaling Pathway—CASP7—vitiligo	0.00496	0.00807	CbGpPWpGaD
Minocycline—CYCS—Caspase Cascade in Apoptosis—CASP7—vitiligo	0.00481	0.00783	CbGpPWpGaD
Minocycline—ALOX5—thyroid gland—vitiligo	0.00459	0.0119	CbGeAlD
Minocycline—IL1B—NOD pathway—CASP7—vitiligo	0.00458	0.00744	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—GZMB—vitiligo	0.0045	0.00733	CbGpPWpGaD
Minocycline—CASP3—Caspase Cascade in Apoptosis—GZMB—vitiligo	0.00424	0.0069	CbGpPWpGaD
Minocycline—CASP3—Apoptotic execution phase—CASP7—vitiligo	0.00418	0.0068	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—CASP7—vitiligo	0.00412	0.00671	CbGpPWpGaD
Minocycline—MMP9—Osteopontin-mediated events—CD44—vitiligo	0.00391	0.00636	CbGpPWpGaD
Minocycline—CASP3—Amyotrophic lateral sclerosis (ALS)—CAT—vitiligo	0.00389	0.00632	CbGpPWpGaD
Minocycline—CASP3—Caspase Cascade in Apoptosis—CASP7—vitiligo	0.00388	0.00632	CbGpPWpGaD
Minocycline—CASP1—Apoptosis Modulation and Signaling—CASP7—vitiligo	0.00387	0.00629	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—GZMB—vitiligo	0.00385	0.00627	CbGpPWpGaD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—vitiligo	0.00379	0.00616	CbGpPWpGaD
Minocycline—CYCS—Alzheimers Disease—CASP7—vitiligo	0.00371	0.00603	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—GZMB—vitiligo	0.00368	0.00599	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—CASP7—vitiligo	0.00353	0.00574	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—CASP7—vitiligo	0.0035	0.00569	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—CASP7—vitiligo	0.00344	0.0056	CbGpPWpGaD
Minocycline—CYCS—Apoptosis Modulation and Signaling—CASP7—vitiligo	0.00331	0.00539	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—GZMB—vitiligo	0.00327	0.00531	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—GZMB—vitiligo	0.00311	0.00506	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—CASP7—vitiligo	0.00299	0.00487	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—CASP7—vitiligo	0.00299	0.00487	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—GZMB—vitiligo	0.00296	0.00481	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—CASP7—vitiligo	0.00285	0.00463	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—CASP7—vitiligo	0.00271	0.0044	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—CASP7—vitiligo	0.00271	0.0044	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—SH2B3—vitiligo	0.00268	0.00436	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—CASP7—vitiligo	0.00267	0.00435	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—CASP7—vitiligo	0.00265	0.00431	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—CTLA4—vitiligo	0.00263	0.00427	CbGpPWpGaD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—vitiligo	0.00263	0.00427	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MITF—vitiligo	0.00253	0.00412	CbGpPWpGaD
Minocycline—CASP3—Degradation of the extracellular matrix—CD44—vitiligo	0.00242	0.00394	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—CTLA4—vitiligo	0.00238	0.00387	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—CASP7—vitiligo	0.00237	0.00385	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—GZMB—vitiligo	0.00236	0.00384	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—NLRP1—vitiligo	0.00235	0.00382	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—CD8A—vitiligo	0.00228	0.00371	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—CAT—vitiligo	0.00226	0.00368	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—CASP7—vitiligo	0.00216	0.00352	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—CASP7—vitiligo	0.00211	0.00343	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—IL2RA—vitiligo	0.00205	0.00334	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—IL2RA—vitiligo	0.00205	0.00334	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—GZMB—vitiligo	0.00197	0.0032	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—CD44—vitiligo	0.00192	0.00313	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—GZMB—vitiligo	0.00191	0.0031	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IL2RA—vitiligo	0.00182	0.00296	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—CASP7—vitiligo	0.0018	0.00293	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—CAT—vitiligo	0.0018	0.00292	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—CASP7—vitiligo	0.00174	0.00284	CbGpPWpGaD
Minocycline—CASP1—Immune System—LRR1—vitiligo	0.00171	0.00279	CbGpPWpGaD
Minocycline—MMP9—Degradation of the extracellular matrix—CD44—vitiligo	0.00168	0.00274	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IL2RA—vitiligo	0.00165	0.00268	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—CD8A—vitiligo	0.00165	0.00268	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—CASP7—vitiligo	0.00164	0.00266	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—CTLA4—vitiligo	0.00158	0.00258	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—CD80—vitiligo	0.00152	0.00247	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—CAT—vitiligo	0.00152	0.00247	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—CASP7—vitiligo	0.00148	0.00241	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	0.00148	0.0024	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—SH2B3—vitiligo	0.00144	0.00234	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IL2RA—vitiligo	0.00141	0.00229	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—CD44—vitiligo	0.0014	0.00228	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—CD80—vitiligo	0.00138	0.00224	CbGpPWpGaD
Minocycline—CASP1—Immune System—NLRP1—vitiligo	0.00137	0.00223	CbGpPWpGaD
Minocycline—CASP1—Immune System—HERC2—vitiligo	0.0013	0.00211	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—IL2RA—vitiligo	0.00128	0.00209	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—CD80—vitiligo	0.00112	0.00182	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL2RA—vitiligo	0.0011	0.00179	CbGpPWpGaD
Minocycline—IL1B—Immune System—LRR1—vitiligo	0.00107	0.00174	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IFIH1—vitiligo	0.00102	0.00166	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CCR6—vitiligo	0.00102	0.00166	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CAT—vitiligo	0.00102	0.00166	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—CD44—vitiligo	0.00102	0.00165	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL2RA—vitiligo	0.000959	0.00156	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—CD80—vitiligo	0.000916	0.00149	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	0.00089	0.00145	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—CD44—vitiligo	0.000877	0.00143	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—CD80—vitiligo	0.000876	0.00142	CbGpPWpGaD
Minocycline—IL1B—Immune System—NLRP1—vitiligo	0.000856	0.00139	CbGpPWpGaD
Minocycline—IL1B—Immune System—HERC2—vitiligo	0.000811	0.00132	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—CD44—vitiligo	0.000705	0.00115	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—CD80—vitiligo	0.000664	0.00108	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL2RA—vitiligo	0.000599	0.000975	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFIH1—vitiligo	0.000596	0.000969	CbGpPWpGaD
Minocycline—CASP1—Immune System—CCR6—vitiligo	0.000596	0.000969	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—CD80—vitiligo	0.000543	0.000883	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CAT—vitiligo	0.000497	0.000808	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IL2RA—vitiligo	0.000482	0.000784	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD44—vitiligo	0.000458	0.000745	CbGpPWpGaD
Minocycline—CASP1—Immune System—CTLA4—vitiligo	0.000452	0.000735	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CD80—vitiligo	0.000449	0.00073	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SH2B3—vitiligo	0.000448	0.000729	CbGpPWpGaD
Minocycline—IL1B—Immune System—CCR6—vitiligo	0.000373	0.000606	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFIH1—vitiligo	0.000373	0.000606	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GSTT1—vitiligo	0.000365	0.000594	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—CD44—vitiligo	0.000364	0.000592	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MC1R—vitiligo	0.000356	0.000579	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD8A—vitiligo	0.000347	0.000565	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL2RA—vitiligo	0.000313	0.000509	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CD44—vitiligo	0.000303	0.000493	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD44—vitiligo	0.000286	0.000466	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTLA4—vitiligo	0.000282	0.000459	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCR6—vitiligo	0.000266	0.000433	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD80—vitiligo	0.000261	0.000425	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SH2B3—vitiligo	0.000252	0.00041	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GZMB—vitiligo	0.000251	0.000408	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2RA—vitiligo	0.000248	0.000404	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MC1R—vitiligo	0.000247	0.000402	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CAT—vitiligo	0.000246	0.0004	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GSTM1—vitiligo	0.000232	0.000378	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTT1—vitiligo	0.000225	0.000366	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD8A—vitiligo	0.000217	0.000353	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MC1R—vitiligo	0.000215	0.000349	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2RA—vitiligo	0.000196	0.000318	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CD44—vitiligo	0.000187	0.000304	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR6—vitiligo	0.000185	0.0003	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SH2B3—vitiligo	0.000175	0.000285	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GZMB—vitiligo	0.000174	0.000283	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD80—vitiligo	0.000163	0.000266	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR6—vitiligo	0.00016	0.000261	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SH2B3—vitiligo	0.000152	0.000247	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CAT—vitiligo	0.000152	0.000247	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GZMB—vitiligo	0.000151	0.000246	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTM1—vitiligo	0.000143	0.000233	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2RA—vitiligo	0.00014	0.000227	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CD80—vitiligo	0.000117	0.00019	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2RA—vitiligo	9.7e-05	0.000158	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2RA—vitiligo	8.42e-05	0.000137	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CD80—vitiligo	8.1e-05	0.000132	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CD80—vitiligo	7.03e-05	0.000114	CbGpPWpGaD
